Designing Constructs That Fit Your Vectors: The Compatibility Check Most Teams Skip

The perfect construct on a slide can be impossible in your actual vector library. The tag is on the wrong terminus, the insert contains a forbidden Type IIS site, the cleavage junction leaves four unwanted residues, or the signal peptide duplicates one already encoded by the backbone. None is a protein-design failure. All can cost a week of cloning.

Construct design and vector selection are often treated as consecutive tasks. They should be solved together. A candidate is not ready when its domain boundaries look sensible; it is ready when the protein architecture, DNA assembly, reading frame, host, selection system, and downstream assay are mutually compatible.

Key Takeaways

• Vector compatibility is part of construct design. Check it before synthesis, not after ranking proteins.
• Exact, partial, and no-match are useful categories. An exact match is build-ready; a partial match needs defined modification; no-match requires a new backbone or different construct.
• Junction residues matter. Scar sequences can alter cleavage, stability, localization, and crystallization.
• The same protein architecture can require different DNA designs. Restriction cloning, Gibson assembly, Golden Gate, Gateway, and recombination systems impose different constraints.
• Validate the expressed product, not only the plasmid map. Translate every junction and simulate processing.
• Design around the organization’s real component library. Reusing validated tags, linkers, signals, and vectors reduces experimental uncertainty.

A Construct Has More Parts Than the Target Sequence

A protein-expression construct may include:

• promoter and regulatory elements;
• untranslated regions or ribosome-binding sequence;
• secretion signal or signal anchor;
• affinity tag;
• solubility or folding partner;
• linker;
• protease-recognition site;
• target domain boundaries;
• localization or retention motif;
• stop codon or downstream fusion;
• terminator and selection cassette.

The protein-level order is not enough. Each component has direction, frame, host, processing, and junction requirements.

The Compatibility Check

1. Expression system and promoter

Confirm that the vector’s promoter, regulatory machinery, origin, and selection marker match the intended host and workflow. A mammalian secretion construct cannot be rescued by perfect protein boundaries in a bacterial expression backbone.

2. Tag position

If the design requires an N-terminal MBP fusion, a vector encoding only a C-terminal His tag is not an exact match. Decide whether the tag is needed during expression, purification, detection, immobilization, or all four.

3. Reading frame and start/stop logic

Translate the assembled open reading frame. Check:

• initiator methionine and start codon context;
• fusion reading frame;
• presence or absence of target stop codon;
• residues encoded by cloning overhangs;
• duplicated or missing linker residues;
• frame across recombination scars;
• unintended translation into vector sequence.

4. Cleavage geometry

Proteases have preferences beyond the nominal recognition site. The target’s first residue after cleavage may affect efficiency, and residual N-terminal residues can matter for activity or crystallization. Simulate the exact processed product.

5. Signal peptides and localization

Do not combine a native secretion signal with a vector-encoded signal peptide unless deliberately designed. Confirm where cleavage is expected and whether the mature chain begins at the desired residue.

6. Assembly-method constraints

Restriction sites, overhang grammar, homology arms, recombination sites, and domestication requirements determine whether a design is physically buildable.

Exact Match, Partial Match, or No Match

Exact match

The vector already provides the required host, promoter, tag orientation, cleavage site, reading frame, localization signal, assembly route, and selection system. Only the intended insert needs to be built.

Partial match

The vector is usable after a defined modification: swapping a tag, adding a linker, removing an internal restriction site, or changing a signal peptide. Record the modification as a separate build step with its own validation.

No match

The backbone conflicts with a hard requirement, such as host, secretion pathway, fusion direction, or assembly standard. Forcing the construct into it creates a new experimental variable and often false economy.

Assembly Method Changes the Design

Restriction–ligation cloning

Simple and robust when suitable sites exist. Internal sites, directional-site availability, and scar residues constrain the design.

Gibson assembly

Overlapping DNA fragments can be joined without relying on a standard part grammar (Gibson et al., 2009). Compatibility moves into homology-arm design, fragment complexity, repeats, and synthesis constraints.

Golden Gate and MoClo

Type IIS enzymes cut outside their recognition sites, enabling ordered multi-part assembly with defined overhangs. The power comes from standardized part positions; the burden is domestication and overhang compatibility. MoClo formalized modular multigene assembly from reusable parts (Weber et al., 2011).

Recombination systems

Gateway and related systems accelerate transfer among destination vectors but can leave defined recombination-derived residues. Those are acceptable for many assays and problematic for others.

The best method is the one already validated for the host and library unless the protein’s requirements justify changing it.

Junctions Are Protein Sequence

Teams often review the target and ignore the residues created between components. Those residues can:

• block protease access;
• create a new protease site;
• add hydrophobicity to a soluble terminus;
• disrupt an N-end-rule-sensitive product;
• alter signal-peptide cleavage;
• form an unintended linker helix;
• remain ordered and interfere with a crystal lattice;
• introduce charge beside a binding site.

For every candidate, write the final amino-acid sequence before and after intended processing. Highlight which residues come from the vector, insert, linker, and assembly scar.

Build a Component Library That Captures Evidence

A useful component record contains:

• sequence and version;
• function;
• compatible host and vector families;
• orientation and frame;
• cleavage or processing behavior;
• known junction preferences;
• expression evidence;
• assay limitations;
• intellectual-property or distribution constraints where relevant.

Validated components reduce uncertainty. If a specific SUMO–protease junction has worked across 20 proteins, reuse carries evidence. A novel linker generated ad hoc does not.

Make the Library Smaller Before Cloning

Suppose computational design proposes:

• 4 domain boundaries;
• 3 solubility tags;
• 2 tag termini;
• 2 protease sites;
• 2 hosts.

That is 96 theoretical combinations. Your vector inventory may support only 18 exactly, 26 with modifications, and none of the remainder. This is not an inconvenience discovered after prioritization; it is a design-space constraint.

A rational funnel is:

1. define biological requirements;
2. enumerate protein architectures;
3. match them to validated vectors and components;
4. penalize or reject modification-heavy builds;
5. rank the buildable subset by predicted behavior;
6. preserve enough diversity to test the main hypotheses.

Worked Example: A Secreted Cysteine-Rich Domain

The target is a mammalian extracellular domain with three disulfides. The plan requires secretion, an N-terminal signal peptide, a removable C-terminal affinity tag, and a native N terminus after processing.

The vector library contains:

• Vector A: mammalian secretion signal, N-terminal His tag, protease site;
• Vector B: mammalian secretion signal, untagged N terminus, C-terminal Fc fusion;
• Vector C: insect secretion signal, C-terminal His tag, no protease site;
• Vector D: bacterial cytosolic MBP fusion.

Vector B is a partial match if the Fc can be replaced with a cleavable affinity tag. Vector C is a partial match plus a host change. Vectors A and D conflict with hard product requirements.

The team should not select Vector A merely because it is “closest” and then discover the mature N terminus is wrong. Either modify Vector B deliberately or revisit the product profile.

Pre-Cloning Checklist

• Intended host and cellular compartment are defined.
• Protein architecture and component order are explicit.
• Exact expressed amino-acid sequence has been translated.
• Start, stop, and reading-frame logic are correct.
• Signal-peptide and protease cleavage products are simulated.
• Internal restriction or Type IIS sites are checked.
• Junction scars are acceptable.
• Codon design preserves required sequence features.
• Tag orientation fits purification and assay.
• Vector copy number and promoter strength suit the target.
• Selection marker and origin fit the host workflow.
• A tag-cleaved or minimal control is included where needed.
• Sequencing plan covers all assembled junctions.

Vector Matching in Orbion Design

Orbion Design can compare proposed constructs with an organization’s vector library and classify exact, partial, and no-match candidates. Its component library supports reusable tags, linkers, protease sites, signals, and other modules, alongside organization-specific components.

That turns compatibility into a first-class design filter. Instead of handing the cloning team a theoretical construct list, you can hand them a ranked set of architectures that map to real vectors—with the required modifications visible before work begins.

For boundary strategy, see How Many Constructs Should You Screen in Parallel—and Which Ones?. For choosing tags, see Solubility Tags for Difficult and Membrane Proteins.

Bottom Line

A protein construct is only useful if it can be built as intended in the available expression system. Match architecture to vector while the design space is still cheap to change. Translate every junction, simulate every cleavage, and distinguish exact matches from constructs that quietly require a new backbone.

The compatibility check is not administrative cleanup. It is how you prevent cloning mechanics from changing the biological experiment.

References

1. Gibson DG, et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods. 2009. doi:10.1038/nmeth.1318
2. Engler C, Kandzia R, Marillonnet S. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE. 2008. doi:10.1371/journal.pone.0003647
3. Weber E, Engler C, Gruetzner R, Werner S, Marillonnet S. A modular cloning system for standardized assembly of multigene constructs. PLoS ONE. 2011. doi:10.1371/journal.pone.0016765
4. Hartley JL, Temple GF, Brasch MA. DNA cloning using in vitro site-specific recombination. Genome Research. 2000. doi:10.1101/gr.143000
5. Bird LE. High throughput construction and small scale expression screening of multi-tag vectors in Escherichia coli. Methods. 2011. doi:10.1016/j.ymeth.2011.08.002